Cicero, Julien
Trouvilliez, Sarah
Palma, Martine
Ternier, Gaetan
Decoster, Laurine
Happernegg, Eloise
Barois, Nicolas
Van Outryve, Alexandre
Dehouck, Lucie
Bourette, Roland P.
Adriaenssens, Eric
Lagadec, Chann
Tarhan, Cagatay Mehmet
Collard, Dominique
Souguir, Zied
Vandenhaute, Elodie
Maubon, Grégory
Sipieter, François
Borghi, Nicolas
Shimizu, Fumitaka
Kanda, Takashi
Giacobini, Paolo
Gosselet, Fabien
Maubon, Nathalie
Le Bourhis, Xuefen
Van Seuningen, Isabelle
Mysiorek, Caroline
Toillon, Robert-Alain
Article History
Received: 17 July 2023
Accepted: 29 November 2023
First Online: 10 December 2023
Declarations
:
: We obtained ethical approval and adhered to institutional guidelines for using animals for scientific purposes. APAFIS#25871-20200522117321730. Human pericytes are from the cell line named HBPCT and were provided by professor Takashi Kanda's group from Yamagushi University (Japan). The study protocol was approved by local ethic committee and conducted in accordance with the declaration of helsinki, as amended in Somerset West in 1996. the collection and use of CD34+ stem cells derived from cord blood has been approved since 2011 by the research French ministry (CODECOH 2011-1321). The cells were harvested thanks to an agreement etablished between the hospital of Béthune (France) and Université of Artois, Lens (France). Informed consents were obtained from families before starting the study.
: The authors declare no competing interests.